HIV-1 gp120-Specific Antibody-Dependent Cell-Mediated Cytotoxicity Correlates with Rate of Disease Progression

Journal of Immunology

Volumn 157, Issue 5, 1996, Pages 2168-2173

  Baum, Linda L ^a   Cassutt, Kelly J ^a   Knigge, Kevin ^b   Khattri, Roli ^a   Margolick, Joseph ^c   Rinaldo, Charles ^d   Kleeberger, Cynthia A ^c   Nishanian, Parunag ^e   Henrard, Denis R ^b   Phair, John ^f  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b ABBOTT LABORATORIES   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; BLOOD; CLINICAL TRIAL; CYTOTOXICITY TEST; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOLOGY; MALE; MULTICENTER STUDY; PHYSIOLOGY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; VIREMIA; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIBODIES, VIRAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CYTOTOXICITY TESTS, IMMUNOLOGIC; DISEASE PROGRESSION; HIV ENVELOPE PROTEIN GP120; HIV SEROPOSITIVITY; HIV SEROPREVALENCE; HIV-1; HUMANS; MALE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; VIREMIA;

EID: 0030240623     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Blumberg, R. S., T. Paradis, K. L. Hartshorn, M. Vogt, D. D. Ho, M. S. Hirsch, J. Leban, V. L. Sato, and R. T. Schooley. 1987. Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus. J. Infect. Dis. 156:878.
2. Ojo-Amaize, E. A., P. Nishanian, D. E. Keith, R. L. Houghton, D. F. Heitjan, J. L. Fahey, and J. V. Giorgi. 1987. Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells. J. Immunol. 139:2458.
3. Riviere, Y., F. Tanneau-Salvadori, A. Regnault, O. Lopez, P. Sansonetti, B. Guy, M. P. Kieny, J. J. Fournal, and L. Montagnier. 1989. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins. J. Virol. 63:2270.
4. Tanneau, F., M. McChesney, O. Lopez, P. Sansonetti, L. Montagnier, and Y. Riviere. 1990. Primary cytotoxicity against the envelope glycoprotein of human immunodeficiency virus-1: evidence for antibody-dependent cellular cytotoxicity in vivo. J. Infect. Dis. 162:837.
5. Lyerly, H. K., D. L. Reed, T. J. Matthews, A. J. Langlois, P. A. Ahearne, S. R. Petteway, and K. J. Weinhold. 1987. Anti-GP120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC. AIDS Res. Hum. Retroviruses 3:409.
6. Nishanian, P. G., E. Ojo-Amaize, C. H. Uittenbogaart, and J. V. Giorgi. 1988. A simple and rapid method for preparation of HIV-expressing targets for functional assays. J. Immunol. Methods 107:261.
7. Rook, A. H., H. C. Lane, T. Folks, S. Mccoy, H. Alter, and A. S. Fauci. 1987. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. J. Immunol. 138:1064.
8. Ljunggren, K., B. Bottinger, G. Biberfeld, A. Karlson, E. M. Fenyo, and M. Jondal. 1987. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. J. Immunol. 139:2263.
9. Ahmad, A., R. Morisset, R. Thomas, and J. Menezes. 1994. Evidence for a defect of antibody-dependent cellular cytotoxic (ADCC) effector function and anti-HIV gp 120/41-specific ADCC-mediating antibody titers in HIV-infected individuals. J. Acquir. Immune. Defic. Syndr. 7:428.
10. Broliden, K., E. Sievers, P. Tovo, V. Moschese, G. Scarlatti, P. Broliden, C. Fundaro, and P. Rossi. 1993. Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-infected mothers and their children. Clin. Exp. Immunol. 93:56.
11. Sawyer, L. A., D. A. Katzenstein, R. M. Hendry, E. J. Boone, L. K. Vujcic, C. C. Williams, S. L. Zeger, A. J. Saah, C. R. Rinaldo, J. P. Phair, J. V. Giorgi, and G. V. Quinnan, Jr. 1990. Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection. AIDS Res. Hum. Retroviruses 6:341.
12. Ljunggren, K., V. Moschese, P. Broliden, C. Giaquinto, I. Quinti, E. Fenyo, B. Wahren, P. Rossi, and M. Jondal. 1990. Antibodies mediating cellular cytov toxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers. J. Infect. Dis. 161:198.
13. Shepp, D. H., S. Chakrabarti, B. Moss, and G. V. Quinnan, Jr. 1988. Antibody-dependent cellular cytotoxicity specific for the envelope antigens of human immunodeficiency virus. J. Infect. Dis. 157:1260.
14. Ojo-Amaize, E., P. G. Nishanian, D. F. Heitjan, A. Rezai, I. Esmail, E. Korns, R. Detels, J. Fahey, and J. V. Giorgi. 1989. Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression. J. Clin. Immunol. 9:454.
15. Dalgleish, A., A. Slinclair, M. Steel, D. Beatson, C. Ludlam, and J. Habeshaw. 1990. Failure of ADCC to predict HIV-associated disease progression or outcome in haemophilic cohort. Clin. Exp. Immunol. 81:5.
16. Kaslow, R., D. Ostrow, R. Detels, J. Phair, B. Polk, and C. Rinaldo. 1987. The multicenter AIDS cohort study: rationale, organization, and selected characteristics of the participants. Am. J. Epidemiol. 126:310.
17. Margolick, J., A. Donnenberg, and A. Munoz. 1994. T lymphocyte homeostasis after HIV seroconversion. J. Acqir. Immune. Defic. Syndr. 7:415.
18. Howell, D. N., P. E. Andreotti, J. R. Dawson, and P. Cresswell. 1985. Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line. J. Immunol. 134:971.
19. Pross, H. F., M. G. Baines, P. Rubin, P. Shragge, and M. S. Patterson. 1981. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J. Clin. Immunol. 1:52.
20. Baum, L., R. Mehrotra, M. Murphy, K. Cassutt, K. Knigge, and J. Phair. 1993. ADCC against gp120 in HIV positive long term survivors. AIDS Res. Hum. Retroviruses 9(Suppl.)1:S40.
21. Coombs, R. W., D. R. Henrard, W. F. Mehaffey, J. Gibson, E. Eggen, T. C. Quinn, and J. Phillips. 1993. Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. J. Clin. Microbiol. 31:1980.
22. Homsy, J., M. Meyer, M. Tateno, S. Clarkson, and J. Levy. 1989. The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science 244:1357.
23. Weiss, R. A., P. R. Clapham, J. N. Weber, A. G. Dalgleish, L. A. Lasky, and P. W. Berman. 1986. Variable and conserved neutralization antigens of human immunodeficiency virus. Nature 324:572.
24. Javaherian, K., A. Langlois, C. McDanal, K. Ross, L. Eckler, C. Jellis, A. Profy, J. Rusche, D. Bolognesi, S. Putney, and T. Matthews. 1989. Principal neutralizing domain of the human immunodeficiency virus Type 1 envelope protein. Proc. Natl. Acad. Sci. USA 86:6768.
25. LaRosa, G., J. Davide, K. Weinhold, J. Waterbury, A. Profy, J. Lewis, A. Langlois, G. Dreesman, R. Boswell, P. Shadduck, L. Holley, M. Karplus, D. Bolognesi, T. Matthews, E. Emini, and S. Putney. 1990. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 249:932.
26. Bottinger, B., K. Ljunggren, A. Karlsson, K. Krohn, E. Fenyo, and G. Biberfeld. 1988. Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type 1. Clin. Exp. Immunol. 73:339.
27. Ljunggren, K., P. A. Broliden, L. Morfeldt-Manson, M. Jondal, and B. Wahren. 1988. IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages. Clin. Exp. Immunol. 73:343.
28. Jenkins, M., D. Landers, D. Williams-Herman, D. Wara, R. Viscarello, H. Hammill, M. Kline, W. Shearer, E. Charlebois, and S. Kohl. 1994. Association between anti-human immunodeficiency virus type 1 (HIV-1) antibody-dependent cellular cytotoxicity antibody titers at birth and vertical transmission of HIV-1. J Infect. Dis. 170:308.